TY - CHAP
M1 - Book, Section
TI - Pharmacoeconomics
A1 - Sutton, S. Scott
A2 - Sutton, S. Scott
PY - 2020
T2 - McGraw Hill’s NAPLEX® Review Guide, 4e
AB - Pharmacoeconomics is the description and analysis of the costs of drug therapy to health care systems and society. Pharmacoeconomic studies identify, measure, and compare the costs and consequences of pharmaceutical products and services. Decision makers use these methods to evaluate and compare the total costs of treatment options and the outcomes associated with these options. To show this graphically, think of two sides of an equation: (1) the inputs (costs) used to obtain and use the drug and (2) the health-related outcomes (Figure 70-1). The center of the equation, the drug product, is symbolized by Rx. If only the left-hand side of the equation is measured without regard for outcomes, this is a cost analysis. If only the right-hand side of the equation is measured without regard to costs, this is a clinical or outcome study. A pharmacoeconomic analysis measures both sides of the equation. Outcomes research is defined as an attempt to identify, measure, and evaluate the end results of health care services. It may include not only clinical and economic consequences, but also outcomes, such as patient health status and satisfaction with their health care. Pharmacoeconomics is a type of outcomes research, but not all outcomes research is pharmacoeconomic research.
SN -
PB - McGraw-Hill Education
CY - New York, NY
Y2 - 2021/11/27
UR - accesspharmacy.mhmedical.com/content.aspx?aid=1179736628
ER -